Liminatus Pharma Inc. Cla... (LIMN)
NASDAQ: LIMN
· Real-Time Price · USD
14.67
-5.64 (-27.77%)
At close: Jun 13, 2025, 3:59 PM
14.42
-1.68%
After-hours: Jun 13, 2025, 05:58 PM EDT
Company Description
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.
The company is based in LA Palma, California.
Liminatus Pharma Inc. Class A Common Stock
| Country | United States |
| IPO Date | May 1, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Chris Kim J.D., L.L.M. |
Contact Details
Address: 6 Centerpointe Drive La Palma, United States | |
| Website | https://liminatuspharma.com |
Stock Details
| Ticker Symbol | LIMN |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001971387 |
| CUSIP Number | n/a |
| ISIN Number | US53271X1081 |
| Employer ID | 00-0000000 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Chris Kim J.D., L.L.M. | Chief Executive Officer, Treasurer & Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 04, 2025 | 8-K | Current Report |
| Jun 02, 2025 | 10-Q | Quarterly Report |
| Jun 02, 2025 | 8-K/A | [Amend] Current Report |
| May 15, 2025 | NT 10-Q | Filing |
| May 08, 2025 | SCHEDULE 13D | Filing |
| May 07, 2025 | SCHEDULE 13D | Filing |
| May 06, 2025 | 8-K | Current Report |
| May 01, 2025 | 3 | Filing |
| Apr 30, 2025 | 3 | Filing |
| Apr 30, 2025 | 3 | Filing |